Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone

Karin Jacob, Mukta Webber, Dafna Benayahu, Hynda K. Kleinman

Research output: Contribution to journalArticlepeer-review

Abstract

The mechanism underlying the 'organ-specific' metastasis of prostate cancer cells to the bone is still poorly understood. It is not clear whether the cells only invade the bone and proliferate there or whether they invade many tissues but survive mainly in the bone ('seed and soil'). Extracts from various organs were used as chemoattractants in the in vitro chemotaxis and invasion assays. Results show that, in comparison with extracts of other tissues, bone extracts promote a 2- to 4-fold increase in chemotaxis by human prostate epithelial cells and a 4-fold increase in the invasive ability of human prostate carcinoma cells. The purified active factor from bone and from marrow stromal-cell-conditioned medium is a low glycosylated osteonectin that specifically promotes the invasive ability of bone-metastasizing prostate (and breast) cancer cells but not that of non-bone-metastasizing tumor cells. It does not stimulate the growth of prostate cancer cells in vitro or in vivo. Because osteonectin specifically enhances matrix metalloprotease activity in prostate and breast cancer cells (and not in other tumor cell types), we conclude that prostate cancer cell metastasis to the bone is, in part, mediated by the ability of osteonectin to promote migration, protease activity, and invasion.

Original languageEnglish
Pages (from-to)4453-4457
Number of pages5
JournalCancer Research
Volume59
Issue number17
StatePublished - 1 Sep 1999

Fingerprint

Dive into the research topics of 'Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone'. Together they form a unique fingerprint.

Cite this